Sandbox:ap: Difference between revisions
Jump to navigation
Jump to search
Created page with " {| class="wikitable" ! colspan="4" |Factors influencing Sestamibi-SPECT scan |- | colspan="2" |Biological factors | |Sensitivity |- |Biochemical factors |Serum calcium |Highe..." |
|||
| (51 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
{| | {{familytree/start |summary=Sample 1}} | ||
{{familytree | | | | | | | | | | | | | | | | A01 |A01=Hypercalcemia}} | |||
|- | {{familytree | | | | | | | | | |,|-|-|-|-|-|-|^|-|-|-|-|-|-|.| | | }} | ||
| | {{familytree | | | | | | | | | B01 | | | | | | | | | | | | B02 | | |B01=Related to Parathyroid gland|B02=Unrelated to parathyroid gland}} | ||
| | {{familytree | | | | |,|-|-|-|-|+|-|-|-|-|.| | | | | | | | |!| }} | ||
| | {{familytree | | | | C01 | | | C02 | | | C03 | | | | | | | |!|C01=Primary hyperparathyroidism|C02=Secondary hyperparathyroidism|C03=Tertiary hyperparathyroidism}} | ||
|- | {{familytree | | |,|-|^|-|.| | | | | | | | | | | | | | | | |!| | }} | ||
| | {{familytree | | D01 | | D02 | | | | | | | | | | | | | | | |!| | |D01=Typical primary hyperparathyroidism|D02=Familial hypocalciuric hypercalcemia}} | ||
| | {{familytree | | | | | | | | | | | | | | | | | | | | | | | |!| | |}} | ||
| | {{familytree | | | | | | | |,|-|-|-|-|-|-|-|v|-|-|-|-|-|v|-|^|-|-|-|-|v|-|-|-|-|.| | |}} | ||
| | {{familytree | | | | | | | E01 | | | | | | E02 | | | | E03 | | | | | E04 | | | E05 | |E01=Malignancy|E02=Medication induced|E03=Nutritional|E04=Granulomatous disease|E05=Surgical}} | ||
|- | {{familytree | | | | | |,|-|^|-|.| | | |,|-|^|-|.| | |,|-|^|-|.| | | |!| | | | |!|}} | ||
| | {{familytree | | | | | F01 | | F02 | | F03| | F04| | F05 | | F06 | | F07 | | | F08| |F01=Para-neoplastic syndrome: Parathyroid hormone related peptide|F02=Metaplasia: Hypercalcemia due to bone destruction|F03=Thiazide diuretics|F04=Lithium|F05=Milk alkali syndrome|F06=Vitamin D toxicity|F07=Sarcoidosis|F08=Immobilization}} | ||
| | {{familytree/end}} | ||
| | |||
| | =Codes= | ||
| | <div style="text-align: center;">'''Corrected total calcium = measured total calcium + 0.8 (4.0 − serum albumin)''' </div> | ||
| | |||
|Vitamin D | |||
<div style="width: 70%;"> | |||
<br style="clear:left" /> | |||
==References== | |||
Latest revision as of 15:49, 5 March 2018
| Hypercalcemia | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Related to Parathyroid gland | Unrelated to parathyroid gland | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Primary hyperparathyroidism | Secondary hyperparathyroidism | Tertiary hyperparathyroidism | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Typical primary hyperparathyroidism | Familial hypocalciuric hypercalcemia | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Malignancy | Medication induced | Nutritional | Granulomatous disease | Surgical | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Para-neoplastic syndrome: Parathyroid hormone related peptide | Metaplasia: Hypercalcemia due to bone destruction | Thiazide diuretics | Lithium | Milk alkali syndrome | Vitamin D toxicity | Sarcoidosis | Immobilization | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Codes
Corrected total calcium = measured total calcium + 0.8 (4.0 − serum albumin)